待处理
入排:排除
图源:待检查
Re: Pain and Health-related Quality of Life with Olaparib Versus Physician's Choice of Next-generation Hormonal Drug in Patients with Metastatic Castration-resistant Prostate Cancer with Homologous Recombination Repair Gene Alterations (PROfound): An Open-label, Randomised, Phase 3 Trial.
Sola Adeleke, Aruni Ghose, Stergios Boussios
Eur Urol 84(2) 246-247
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板